Follow
Richard Sloan
Richard Sloan
Verified email at exseed.ed.ac.uk
Title
Cited by
Cited by
Year
The role of unintegrated DNA in HIV infection
RD Sloan, MA Wainberg
Retrovirology 8, 1-15, 2011
2152011
Antiviral drug resistance and the need for development of new HIV-1 reverse transcriptase inhibitors
EL Asahchop, MA Wainberg, RD Sloan, CL Tremblay
Antimicrobial agents and chemotherapy 56 (10), 5000-5008, 2012
1172012
Tetherin restricts direct cell-to-cell infection of HIV-1
BD Kuhl, RD Sloan, DA Donahue, T Bar-Magen, C Liang, MA Wainberg
Retrovirology 7, 1-13, 2010
1152010
Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor
T Bar-Magen, RD Sloan, DA Donahue, BD Kuhl, A Zabeida, H Xu, ...
Journal of Virology 84 (18), 9210-9216, 2010
1082010
Novel therapeutic strategies targeting HIV integrase
PK Quashie, RD Sloan, MA Wainberg
BMC medicine 10, 1-11, 2012
952012
Antiviral Resistance Mutations Potentiate hepatitis B virus Immune Evasion through Disruption of its Surface Antigen a Determinant
RD Sloan, S Ijaz, PL Moore, TJ Harrison, CG Teo, RS Tedder
Antiviral therapy 13 (3), 439-448, 2008
762008
The viral protein Tat can inhibit the establishment of HIV-1 latency
DA Donahue, BD Kuhl, RD Sloan, MA Wainberg
Journal of virology 86 (6), 3253-3263, 2012
752012
Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis
RD Sloan, BD Kuhl, T Mesplède, J Münch, DA Donahue, MA Wainberg
Journal of virology 87 (14), 8110-8123, 2013
712013
Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase
PK Quashie, T Mesplède, YS Han, T Veres, N Osman, S Hassounah, ...
Antimicrobial agents and chemotherapy 57 (12), 6223-6235, 2013
692013
IFITM proteins inhibit HIV-1 protein synthesis
WYJ Lee, RM Fu, C Liang, RD Sloan
Scientific reports 8 (1), 14551, 2018
682018
HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assays
T Bar-Magen, DA Donahue, EI McDonough, BD Kuhl, VH Faltenbacher, ...
Aids 24 (14), 2171-2179, 2010
682010
Stage-dependent inhibition of HIV-1 replication by antiretroviral drugs in cell culture
DA Donahue, RD Sloan, BD Kuhl, T Bar-Magen, SM Schader, ...
Antimicrobial agents and chemotherapy 54 (3), 1047-1054, 2010
582010
Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes
RD Sloan, DA Donahue, BD Kuhl, T Bar-Magen, MA Wainberg
552010
Comparative biochemical analysis of HIV-1 subtype B and C integrase enzymes
T Bar-Magen, RD Sloan, VH Faltenbacher, DA Donahue, BD Kuhl, ...
Retrovirology 6, 1-10, 2009
542009
Phosphatase PP2A is essential for TH17 differentiation
Q Xu, X Jin, M Zheng, D Rohila, G Fu, Z Wen, J Lou, S Wu, R Sloan, ...
Proceedings of the National Academy of Sciences 116 (3), 982-987, 2019
412019
The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism
BD Kuhl, V Cheng, DA Donahue, RD Sloan, C Liang, J Wilkinson, ...
PLoS One 6 (11), e27660, 2011
392011
Genotyping of acute HBV isolates from England, 1997–2001
RD Sloan, AL Strang, ME Ramsay, CG Teo
Journal of clinical virology 44 (2), 157-160, 2009
392009
IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity
M Gómez-Herranz, J Taylor, RD Sloan
Journal of Biological Chemistry 299 (1), 2023
312023
Latent HIV-1 can be reactivated by cellular superinfection in a Tat-dependent manner, which can lead to the emergence of multidrug-resistant recombinant viruses
DA Donahue, SM Bastarache, RD Sloan, MA Wainberg
Journal of virology 87 (17), 9620-9632, 2013
312013
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral load
VG Kramer, SM Schader, M Oliveira, SP Colby-Germinario, DA Donahue, ...
Antimicrobial agents and chemotherapy 56 (8), 4154-4160, 2012
302012
The system can't perform the operation now. Try again later.
Articles 1–20